• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasma protein binding of furosemide in the elderly.

作者信息

Pacifici G M, Viani A, Schulz H U, Frercks H J

出版信息

Eur J Clin Pharmacol. 1987;32(2):199-202. doi: 10.1007/BF00542196.

DOI:10.1007/BF00542196
PMID:3582485
Abstract

The protein binding of furosemide was investigated in plasma from 22 old and 11 young subjects by equilibrium dialysis. The unbound fraction of furosemide was 3.16% in plasma from the elderly and 1.7% in plasma from the young. A significant correlation was found between the unbound fraction of furosemide and the plasma concentration of albumin. The average number of binding sites was 3.8 (elderly) and 2.7 (young) 10(-6) mol/g albumin. The average association constant (K) was 4.3 (elderly) and 4.2 (young) 10(5) M-1. By increasing the concentration of furosemide up to 200 micrograms/ml buffer the unbound fraction of the drug rose to 5.2% (elderly) and 3.5% (young).

摘要

相似文献

1
Plasma protein binding of furosemide in the elderly.
Eur J Clin Pharmacol. 1987;32(2):199-202. doi: 10.1007/BF00542196.
2
Serum protein binding of furosemide in newborn infants and children.速尿在新生儿和儿童中的血清蛋白结合情况。
Dev Pharmacol Ther. 1987;10(6):413-21. doi: 10.1159/000457773.
3
Protein binding studies of furosemide and penbutolol.呋塞米和喷布洛尔的蛋白质结合研究。
Arzneimittelforschung. 1985;35(6):899-902.
4
Bilirubin displaces furosemide from serum protein: the effect is greater in newborn infants than adult subjects.胆红素可将呋塞米从血清蛋白中置换出来:这种作用在新生儿中比在成人中更明显。
Dev Pharmacol Ther. 1989;14(2):90-5.
5
Furosemide binding to human albumin and plasma of nephrotic children.呋塞米与肾病患儿人白蛋白及血浆的结合
Clin Pharmacol Ther. 1975 Feb;17(2):159-65. doi: 10.1002/cpt1975172159.
6
The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.老年患者中呋塞米与血清蛋白的结合:苯丙香豆素的置换作用。
Acta Pharmacol Toxicol (Copenh). 1980 Sep;47(3):202-7. doi: 10.1111/j.1600-0773.1980.tb01560.x.
7
Quantitative contribution of endogenous compounds and hypoalbuminemia in reducing the binding of furosemide in the plasma of newborn infants.
Dev Pharmacol Ther. 1992;18(1-2):39-43.
8
Effect of in vivo increase of free fatty acids on human plasma protein binding of furosemide.体内游离脂肪酸增加对呋塞米人血浆蛋白结合的影响。
Pharmacology. 1982;25(2):73-81. doi: 10.1159/000137726.
9
[Levels of plasma proteins in patients with ene stage renal failure treated with peritoneal dialysis with an addition of furosemide to dialysis fluid].[在透析液中添加呋塞米进行腹膜透析治疗的终末期肾衰竭患者的血浆蛋白水平]
Pol Tyg Lek. 1994;49(6-7):137-40.
10
Plasma protein binding of frusemide in liver disease: effect of hypoalbuminaemia and hyperbilirubinaemia.呋塞米在肝脏疾病中的血浆蛋白结合:低白蛋白血症和高胆红素血症的影响。
Br J Clin Pharmacol. 1989 Aug;28(2):175-8. doi: 10.1111/j.1365-2125.1989.tb05412.x.

引用本文的文献

1
Electroanalysis of Ibuprofen and Its Interaction with Bovine Serum Albumin.布洛芬的电化学分析及其与牛血清白蛋白的相互作用。
Molecules. 2022 Dec 21;28(1):49. doi: 10.3390/molecules28010049.
2
Acute Renal Failure of Nosocomial Origin.医院获得性急性肾衰竭。
Dtsch Arztebl Int. 2019 Mar 1;116(9):149-158. doi: 10.3238/arztebl.2019.0149.
3
Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.呋塞米在健康与疾病状态下的药代动力学和药效学——最新进展

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Effect of plasma protein binding on renal clearance of drugs.血浆蛋白结合对药物肾清除率的影响。
J Pharm Sci. 1980 Apr;69(4):482-3. doi: 10.1002/jps.2600690437.
3
Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.药代动力学概念——药物结合、表观分布容积和清除率。
J Pharmacokinet Biopharm. 1989 Feb;17(1):1-46. doi: 10.1007/BF01059086.
4
Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).呋塞米。药代动力学/药效学综述(第二部分)。
Clin Pharmacokinet. 1990 Jun;18(6):460-71. doi: 10.2165/00003088-199018060-00003.
5
Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.药物血浆和组织结合的测定方法。药代动力学后果。
Clin Pharmacokinet. 1992 Dec;23(6):449-68. doi: 10.2165/00003088-199223060-00005.
Eur J Clin Pharmacol. 1981;20(4):299-305. doi: 10.1007/BF00618781.
4
Relative reference values for clinical chemical and haematological quantities in 'healthy' elderly people.“健康”老年人临床化学和血液学指标的相对参考值。
Acta Med Scand. 1981;209(1-2):1-9. doi: 10.1111/j.0954-6820.1981.tb11542.x.
5
Drug therapy: drug disposition in old age.药物治疗:老年人的药物处置
N Engl J Med. 1982 May 6;306(18):1081-8. doi: 10.1056/NEJM198205063061804.
6
Clinical pharmacokinetics of diuretics.利尿剂的临床药代动力学
Clin Pharmacokinet. 1980 May-Jun;5(3):221-45. doi: 10.2165/00003088-198005030-00003.
7
Furosemide kinetics and dynamics in aged patients.老年患者中呋塞米的动力学和动态变化
Clin Pharmacol Ther. 1983 Aug;34(2):181-9. doi: 10.1038/clpt.1983.150.
8
Role of binding in distribution of furosemide: where is nonrenal clearance?呋塞米分布中结合的作用:非肾清除在哪里?
Fed Proc. 1983 Apr;42(6):1699-702.
9
The influence of age on renal and extrarenal effects of frusemide.年龄对速尿肾脏及肾外效应的影响。
Br J Clin Pharmacol. 1984 Jul;18(1):65-74. doi: 10.1111/j.1365-2125.1984.tb05023.x.
10
Protein binding and drug clearance.蛋白质结合与药物清除率。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:10-7. doi: 10.2165/00003088-198400091-00002.